Contents
Current Angiogenesis (Discontinued), Volume 1 - Number 2
Histidine Rich Glycoprotein, an Endogenous Regulator of Macrophage and Endothelial Biology
, 1(2): 81 - 87Lena Claesson-Welsh and Sonia Tugues
DOI: 10.2174/2211552811201020081
Regulation of Tumor Angiogenesis by the Immune System
, 1(2): 88 - 97Keri Schadler Stewart and Sandra W. Ryeom
DOI: 10.2174/2211552811201020088
To Enhance or to Inhibit Integrin Function in Angiogenesis, that is the Question
, 1(2): 98 - 104Roy Zent and Ambra Pozzi
DOI: 10.2174/2211552811201020098
Neovascular Age-related Macular Degeneration: Past, Present, and Future
, 1(2): 105 - 114Leo A. Kim and Patricia A. D’Amore
DOI: 10.2174/2211552811201020105
Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy
, 1(2): 115 - 124Steven Pirie-Shepherd
DOI: 10.2174/2211552811201020115
Neuropilin Signalling in Vascular Development and Pathology
, 1(2): 125 - 132Alessandro Fantin, Alice Plein and Christiana Ruhrberg
DOI: 10.2174/2211552811201020125
Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy
, 1(2): 133 - 138James M. Dunleavey and Andrew C. Dudley
DOI: 10.2174/2211552811201020133
Mechanisms of Angiogenesis: Perspectives from Antiangiogenic Tumor Therapies
, 1(2): 139 - 147Jeffrey J. Rice, Par Gerwins and Witold W. Kilarski
DOI: 10.2174/2211552811201020139
Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development
, 1(2): 148 - 156William G. Stetler-Stevenson, Dimitra Bourboulia, Liliana Guedez and Sandra Jensen-Taubman
DOI: 10.2174/2211552811201020148
Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
, 1(2): 157 - 167Jennifer Vogel and Kevin Camphausen
DOI: 10.2174/2211552811201020157
Webmaster Contact: info@benthamscience.org